期刊文献+

利多卡因醇质体的理化性质及其皮肤刺激性研究 被引量:3

The Study of Physicochemical Properties and Skin Irritation of Lidocaine Ethosomes
原文传递
导出
摘要 目的:制备利多卡因醇质体,并对其理化性质及皮肤刺激性进行研究。方法:采用超声注入法制备利多卡因醇质体,使用透射电镜观察和激光粒度仪分析其形态、粒径大小及分布,采用透析法和HPLC法测定利多卡因醇质体的包封率,对不同温度下保存60天后的利多卡因醇质体的包封率进行测定以评估其稳定性,通过豚鼠皮肤刺激试验对利多卡因醇质体的皮肤刺激性进行分析。结果:利多卡因醇质体为圆形囊泡结构,粒径为31.33±2.63 nm,多分散指数为0.42±0.21,显示粒径分布较为均匀,其包封率为(52.85±0.36)%,保存在25±1℃时泄露最少,豚鼠完整及破损皮肤经利多卡因醇质体处理后均未见红斑和水肿反应,行组织学检查也未见明显炎症改变。结论:利多卡因醇质体具备理想的理化性质且对皮肤无刺激性,有望成为一种新型经皮局麻制剂。 Objective: To prepare the lidocaine ethosomes and investigate its physicochemical properties and skin irritancy.Methods: The lidocaine ethosomes was prepared by ultrasonic injection method. The morphology was examined by transmission electron microscope. The particle size and distribution were detected by Zetasizer instrument. The free drug was separated by dialysis method and the encapsulation efficiency of lidocaine ethosomes was determined by HPLC. The encapsulation efficiency at different temperatures was determined at sixtieth days to evaluate the stability. The guinea pigs were utilized to investigate the skin irritations of lidocaine ethosomes. Results: The lidocaine ethosomes was spherical vesicles, its size distribution was narrow with polydispersity index of 0.42 ±0.21, and its particle diameter and encapsulation efficiency were 31.33 ±2.63 nm and(52.85 ±0.36)%, respectively, the leakage of lidocaine ethosomes was lowest in storing at 25±1℃. There had no edema and erythema could be observed on the guinea pigs skin, and had no inflammation changes in the histopathological observation. Conclusion: The lidocaine ethosomes with ideal physicochemical properties has no skin irritation and is expected to be a new topical anaesthetic preparation.
出处 《现代生物医学进展》 CAS 2015年第9期1654-1658,共5页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(30902019)
关键词 利多卡因 醇质体 皮肤刺激性 Lidocaine Ethosomes Skin irritancy
  • 相关文献

参考文献20

  • 1Mbah CC,Builders PF,Attama AA.Nanovesicular carriers as alternative drug delivery systems:ethosomes in focus[J].Expert Opin Drug Deliv,2014,11(1):45-59.
  • 2李富利,朱晓亮,彭学标,曾抗.利多卡因醇质体的组方研究及其包封率测定[J].皮肤性病诊疗学杂志,2011,18(1):26-29. 被引量:4
  • 3Liu Xing-yan,Liu Hong,Liu Jian-qiang,et al.Preparation of a ligustrazine ethosome patch and its evaluation in vitro and in vivo[J].Int J Nanomedicine,2011,(6):241-247.
  • 4Mao Xiao-hui,Wo Yan,He Rong,et al.Preparation and characterization of different sizes of ethosomes encapsulated with 5-fluorouracil and its experimental study of permeability in hypertrophic scar[J].J Nanosci nanotechnol,2010,10(7):4178-4183.
  • 5Celia C,Cilurzo F,Trapasso E,et al.Ethosomes and transfersomes containing linoleic acid:physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders[J].Biomed Microdevices,2012,14(1):119-130.
  • 6Tyagi LK,Kumar S,Maurya SS,et al.Ethosomes:novel vesicular carrier for enhanced transdermal drug delivery system[J].Bull Pharm Res,2013,3(1):6-13.
  • 7Rakesd R,Anoop KR.Formulation and optimization of nano-sized ethosomes for enhanced transdermal delivery of cromolyn sodium[J].J Pharm Bioallied Sci,2012,4(4):333-340.
  • 8Lopez-Pinto JM,GonzaIez-Rodriguez ML,Rabasco AM.Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes[J].Int J Pharm,2005,298(1):1-12.
  • 9Megn Shu,Chen Zai-xing,Yang Li-qun,et al.Enhanced transdermal bioavailability of testosterone propionate via surfactant-modified ethosomes[J].Int J Nanomedicine,2013,8:3051-3060.
  • 10Li Gui-ling,Fan Chao,Li Xin-ru,et al.Preparation and In Vitro Evaluation of Tacrolimus-Loaded Ethosomes[J].Scientific World Journal,2012,2012:1-6.

二级参考文献10

  • 1Sintov AC, Shapiro L. New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo [ J ]. J Control Release, 2004,95 (2) :173-183.
  • 2Mustafa MA, Ossama AY, Viviane NF. Lipid vesicles for skin delivery of drugs: Reviewing three decades of research [ J]. International Journal of Pharmaceutics ,2007, 332 : 1-16.
  • 3Touitou E, Dayan N. Ethosomes novel vesicular carriers for enhanced delivery: characterization and skin penetration properties [ J ]. Journal of Controlled Release, 2000,65:403-418.
  • 4Vaibhav D, Dinesh M ,Tathagata D. Melatonin loaded ethanolic liposomes: Physicochemical characterization and enhanced transdermal delivery [ J ]. European JoumaF of Pharmaceutics and Biopharmaceutics,2007 ,67 :398-405.
  • 5Donatella P, Giuseppe D, Domenico M,et al. Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers [ J ]. Journal of Controlled Release, 2005,106:99-110.
  • 6Subheet J, Ashok KT, Bharti S. Formulation and Evaluation of Ethosomes for Transdermal Delivery of Lamivudine [ J]. AAPS PharmSciTech, 2007,4( 8 ): 111.
  • 7Zhao WZ. Preparation of matrine ethosome, its percutaneous permeation in vitro and anti-inflammatory activity in vivo in rats[ J]. J Liposome Res ,2009,24 : 1-8.
  • 8Tadros MI, Ehab R. Enhanced Transdermal Delivery of Salbutamol Sulfate via Ethosomes [ J ]. AAPS Pharm- SciTech, 2007,4 ( 8 ) : 107.
  • 9Lopez-Pinto JM, Gonzalea-Rodriguez ML. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes [ J ]. International Journal of Pharmaceutics, 2005, 298 : 1-12.
  • 10杨效宇,赵佩,李兰兰,焦海胜.两种秋水仙碱醇质体的制备及评价[J].中国药学杂志,2010,45(11):844-848. 被引量:7

共引文献3

同被引文献28

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部